Top compounds associated with response to ADGRE1


Feature Type Standardized
Nominal ANOVA
mRNA SN-38 GDSC1000 pan-cancer AAC 0.079 0.02
mRNA decitabine CTRPv2 pan-cancer AAC -0.065 0.02
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.067 0.02
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.083 0.02
mRNA BRD-K16130065 CTRPv2 pan-cancer AAC 0.17 0.02
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.081 0.02
mRNA thalidomide CTRPv2 pan-cancer AAC 0.12 0.02
mRNA importazole CTRPv2 pan-cancer AAC -0.089 0.02
mRNA BRD-K71935468 CTRPv2 pan-cancer AAC 0.088 0.02
mRNA CAY10603 GDSC1000 pan-cancer AAC -0.07 0.02
Download CSV